Table 1.

Reported cases of G-CSF producing gallbladder carcinoma.

Age	Sex	WBC (/μL)	G-CSF (pg/mL)	Size (mm)	Treatment	Histology	Immunostaining	Outcome	Author
67	Male	27980	225	115	Surgery  + chemotherapy	Moderately differentiated tubular adenocarcinoma	Positive	Alive with a recurrence (16 months)	Our case
78	Male	26050	120	120	Surgery	Adenosquamous carcinoma	Positive	Alive (27 months)	Suzumura et al. [4]
50	Female	19800	800	45	Surgery	Moderately differentiated tubular adenocarcinoma	Positive	Recurrence-free survival (27 months)	Ikeda et al. [7]
62	Male	21400	50.8	120	Surgery	Squamous carcinoma	Positive	Dead (8 months)	Murata et al. [8]
73	Female	36500	1311	100	Chemotherapy	Moderately differentiated tubular adenocarcinoma	Positive	Dead (3 months)	Kuroki et al. [9]
48	Female	15700	54	80	Surgery + chemotherapy	Poorly differentiated adenocarcinoma	Positive	Alive (11 months)	Furihata et al. [10]
73	Male	75200	129	ND	Surgery	Undifferentiated carcinoma	Positive	Alive (18 months)	Omura et al. [11]
71	Male	18600	46	90	Surgery ＋ TAE	Adenosquamous carcinoma	Negative	Dead (6 months)	Nakajima et al. [12]
79	Female	9400	Activity(+)	ND	Surgery + chemotherapy	Undifferentiated carcinoma	Positive	Dead (6 months)	Takeda et al. [13]
55	Female	57900	Activity(+)	130	Surgery + chemotherapy + radiation	Undifferentiated carcinoma	ND	Dead (6 months)	Sakamoto et al. [14]
72	Female	44100	Activity(+)	ND	Immunotherapy	Adenosquamous carcinoma	ND	Dead (54 days)	Takahashi et al. [15]

TAE: transcatheter arterial embolization. ND: Not described.